1. Catalogs
  2. BIOSYNEX
  3. HEMOTRUST®

HEMOTRUST®

HEMOTRUST®

HEMOTRUST®

Product catalog summary
Overview: The HEMOTRUST® rapid test is designed for the detection of hemoglobin in stool samples, aiding in the early detection of colorectal cancer. It is a quick, reliable, and convenient test that provides results in 5 minutes without the need for dietary restrictions.
Specifications:
  • Sensitivity: 94.6%
  • Specificity: 99.3%
  • Storage: 24 months at 2-30°C
Product Details:
  • Ref. 1110002: HEMOTRUST® 25 tests
  • Ref. 6110001: Hemoglobin control, 1 swab for 1 positive control
Solution for Colorectal Cancer: Colorectal cancer is a leading cause of cancer-related deaths. Early detection significantly improves survival rates. The HEMOTRUST® test is designed to detect hemoglobin levels above physiological leakage, reducing false positives and negatives compared to older methods.
Kit Contents:
  • 25 test cassettes
  • 25 extraction buffer vials
  • Instructions for use
Test Procedure:
  1. Collect stool samples using the applicator stick at three different sites.
  2. Insert the applicator stick back into the buffer tube and mix vigorously.
  3. Transfer 2 drops of the diluted sample into the sample well 'S' of the cassette.
  4. Read the result after 5 minutes. Do not interpret after 10 minutes.
Results Interpretation:
  • Negative: No hemoglobin detected.
  • Positive: Hemoglobin detected.
Contact Information: BIOSYNEX SA, 22 Boulevard Sébastien Brant, 67400 ILLKIRCH-GRAFFENSTADEN, France. Phone: +33 3 88 77 57 52, Email: [email protected], Website: www.biosynex.com
See more

Catalog excerpts

HEMOTRUST®-1

Rapid test for the detection of hemoglobin in stool samples # Rapid - Easy handling - Results in 5 minutes # Reliable High performances *: - sensitivity: 94.6% - specificity: 99.3% * Compared to another commercial rapid test. Refer to the instructions for use for more information. # Convenient - Storage 24 months at 2-30°C

 Open the catalog to page 1
HEMOTRUST®-2

THE SOLUTION Colorectal cancer is one of the most commonly diagnosed cancer and a leading cause of cancer-related death. Early detection of colorectal cancer improves the cances of survival and thus reduces mortality. In healthy subjects, trace amounts of blood in stools can be detected in the absence of cancer or other severe pathology. This is called physiological leakage. The threshold of the HEMOTRUST® rapid test was fixed above the threshold corresponding to physiological leak for these traces not to be detected. The first FOB (Fecal Occult Blood) tests commercially available used a gaiac...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.